CompanyCompetitive AnalysisCompany Patent Opposition Analysis

Explore patent oppositions filed by Ucb Pharma against competitors, revealing strategic technology disputes and market positioning. Monitor opposition details, timelines, and disputed innovations to understand competitive dynamics and IP enforcement strategy.

Last updated on: Aug 7, 2025
Patent NumberTitleApplicantOpposition Date

Get instant updates on new opposition filings by the company

Methods Of Altering Bone Growth By Administration Of Sost Or Wise Antagonist Or AgonistOSSIFI MABJul 26, 2023

Explore Ucb Pharma's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Aug 7, 2025
Patent NumberGrant DateTitleTotal Oppositions
Dec 13, 2023Sclerostin Epitopes1
Jul 26, 2023Transdermal Delivery System Including An Interface Mediator1
Jun 21, 2023Treatment For Bone Diseases1
Aug 10, 2022Once Daily Formulation Of Lacosamide1
Sep 22, 2021Sclerostin Epitopes1
Sep 8, 2021Sclerostin Binding Agents1
Aug 5, 2020Pharmaceutical Composition Comprising Brivaracetam And Lacosamide With Synergistic Anticonvulsant Effect1
Jun 6, 2018Polyvinylpyrrolidone For The Stabilization Of A Solid Dispersion Of The Non-Crystalline Form Of Rotigotine2
Aug 30, 2017Pharmaceutical Composition With Synergistic Anticonvulsant Effect1
Jun 14, 2017Multi-Day Patch For The Transdermal Administration Of Rotigotine2

Top competitors of Ucb Pharma

List of top competitors of Ucb Pharma based on patent oppositions.